Author Archives: Patricia Silva, PhD

NeuroViVe Announces Poor Results on its Mitochondrial CicloMulsion Investigational Drug in Acute Myocardial Infarction Patients

NeuroVive Pharmaceutical AB, a company focused on the treatment of acute conditions linked to mitochondria, recently announced that its investigational product CicloMulsion® did not meet the primary clinical endpoint in the phase III CIRCUS trial in patients who have experienced a particular type of heart attack called ST-segment elevation…